SV Investment Corp is a Korea-based venture capital (VC) firm principally engaged in the investment in small to medium enterprises (SMEs). The Company principally engaged in the investment in SMEs and venture companies, overseas investment, establishment and management of business incubation centers, as well as formation of private equity funds (PEF). In addition, the Company also provides initial public offering (IPO), merger and acquisitions (M&A), and secondary support services.

Employees

Sector

Investment Management & Fund Operators

More about the company

Quotes

Date	Price	Change	Volume
24/08/26	KRW 2,625.00	+29.95%	1,064,028
21/08/26	KRW 2,020.00	-4.27%	456,037
20/08/26	KRW 2,110.00	+1.44%	223,172
19/08/26	KRW 2,080.00	-2.80%	537,420

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 24/08/2026			5-day change	1st Jan Change
2,625.00 ^KRW	+29.95%		+19.86%	+53.42%

20/08	KaliVir Immunotherapeutics, Inc. announced that it has received $25 million in funding from Premier Partners, LLC, Quad Investment Management Corp., Nextrans, Flexus Partners Co., Ltd., SV Investment Corporation, Company K Partners Limited	CI
03/07	LinqAlpha Inc. announced that it has received $21.99996 million in funding from a group of investors	CI

Market Cap	158B 114M 97.78M 91.47M 83.63M 158M 10.92B 159M 1.08B 421M 5.49B 428M 419M 18.15B	P/E 2025	-13.1x	P/E 2026	-205x
Enterprise Value	165B 119M 102M 95.63M 87.43M 165M 11.42B 167M 1.13B 440M 5.74B 448M 438M 18.98B	EV / Sales 2025	3.42x	EV / Sales 2026	9.89x
Free-Float	75.22%	Yield 2025 *	-	Yield 2026	-

20/08	KaliVir Immunotherapeutics, Inc. announced that it has received $25 million in funding from Premier Partners, LLC, Quad Investment Management Corp., Nextrans, Flexus Partners Co., Ltd., SV Investment Corporation, Company K Partners Limited	CI
03/07	LinqAlpha Inc. announced that it has received $21.99996 million in funding from a group of investors	CI
18/06	SV Investment Corporation Reports Earnings Results for the Full Year Ended March 31, 2026	CI
30/05	XCENA Inc. announced that it has received KRW 202 billion in funding from a group of investors	CI
28/05	ASTEROMORPH announced that it has received KRW 47 billion in funding from a group of investors	CI
21/05	LinqAlpha Inc. announced that it expects to receive $19.999992 million in funding	CI
14/05	SV Investment Corporation announces Annual dividend, payable on July 16, 2026	CI
14/04	XCENA Inc. announced that it expects to receive KRW 150 billion in funding from a group of investors	CI
26/02	GenEdit Inc. announced that it has received $60 million in funding from a group of investors	CI
13/02	SV Investment Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
14/11	SV Investment Corporation Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
28/10/25	PineTree Therapeutics, Inc. announced that it has received $47.000004 million in funding from a group of investors	CI
22/08/25	PineTree Therapeutics, Inc. announced that it expects to receive $48.00006 million in funding	CI

1 day	+29.95%
1 week	+19.86%
Current month	+49.40%
1 month	+46.08%
3 months	-22.22%
6 months	-39.52%
Current year	+53.42%

SV Investment Corporation Stock

Stocks

A289080

KR7289080004

Investment Management & Fund Operators

Valuation: SV Investment Corporation

Chart: SV Investment Corporation

Latest news : SV Investment Corporation

Quotes and Performance

Course Extremes

Managers and Directors: SV Investment Corporation

Venture Capital

Financials

Company Profile

Quotes

1 week	1,940	2,625
1 month	1,439	2,625
Current year	1,439	5,030
1 year	1,439	5,030
3 years	1,156	5,030
5 years	1,156	5,030
10 years	1,156	8,570

Manager	Title	Age	Since
Won-Ho Hong CEO	Chief Executive Officer	61	30/09/2019
Seong-Ho Park CEO	Chief Executive Officer	57	-
Ji-Hwa Ryu PRN	Corporate Officer/Principal	56	30/06/2023

Director	Title	Age	Since
Seong-Ho Park BRD	Director/Board Member	57	-
Won-Ho Hong BRD	Director/Board Member	61	30/09/2019
Ji-Hwa Ryu BRD	Director/Board Member	56	30/06/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SV INVESTMENT CORPORATION	+29.95%	+19.86%	+47.72%	+35.94%	114M
BB BIOTECH AG	+1.44%	+3.30%	+73.50%	+41.64%	3.82B
HERCULES CAPITAL, INC.	+2.16%	+5.80%	-9.00%	+7.23%	3.23B
HBM HEALTHCARE INVESTMENTS AG	-0.63%	-5.62%	+35.84%	+34.90%	1.95B
MOLTEN VENTURES PLC	+0.36%	+2.45%	+90.92%	+183.95%	1.48B
OCTOPUS APOLLO VCT PLC	0.00%	0.00%	-1.72%	-7.02%	735M
MIRAE ASSET VENTURE INVESTMENT CO., LTD.	+9.52%	-9.26%	+161.18%	+224.74%	610M
BRITISH SMALLER COMPANIES VCT PLC	-2.07%	-2.07%	-5.33%	-8.97%	413M
OCTOPUS TITAN VCT PLC	0.00%	0.00%	-40.68%	-75.18%	394M
PEMBROKE VCT PLC	0.00%	0.00%	-0.53%	-13.02%	373M
Average	+4.07%	+2.48%	+35.19%	+42.42%	1.31B
Weighted average by Cap.	+1.54%	+1.46%	+41.18%	+47.31%

	2025	2026
Net sales	19.98B 14.44M 12.38M 11.58M 10.59M 19.98M 1.38B 20.19M 137M 53.28M 694M 54.23M 53.06M 2.3B	20.52B 14.83M 12.71M 11.89M 10.87M 20.51M 1.42B 20.73M 141M 54.7M 713M 55.68M 54.47M 2.36B
Net income	-5.23B -3.78M -3.24M -3.03M -2.77M -5.23M -362M -5.29M -35.88M -13.95M -182M -14.2M -13.89M -602M	-1B -724K -620K -580K -530K -1M -69.29M -1.01M -6.86M -2.67M -34.79M -2.72M -2.66M -115M
Net Debt	-1.04B -752K -645K -603K -551K -1.04M -72.03M -1.05M -7.14M -2.77M -36.17M -2.82M -2.76M -120M	7.18B 5.19M 4.45M 4.16M 3.8M 7.18M 497M 7.25M 49.22M 19.14M 249M 19.48M 19.06M 825M